Page last updated: 2024-09-04

pixantrone and Lung Neoplasms

pixantrone has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Soni, R; Tandon, V; Tripathi, P1
Cheng, X; Deng, Y; Hu, L; Lai, C; Li, C; Liu, M; Liu, X; Luo, X; Qiu, Q; Song, Y; Su, Y; Zhao, Z; Zheng, H1

Other Studies

2 other study(ies) available for pixantrone and Lung Neoplasms

ArticleYear
Pixantrone confers radiosensitization in KRAS mutated cancer cells by suppression of radiation-induced prosurvival pathways.
    Free radical biology & medicine, 2022, Volume: 190

    Topics: Animals; Cell Line, Tumor; Humans; Isoquinolines; Lung Neoplasms; Mice; Mutation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins p21(ras); Radiation-Sensitizing Agents

2022
Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)-octadecylamine conjugate for lung cancer treatment.
    Drug delivery, 2018, Volume: 25, Issue:1

    Topics: A549 Cells; Amines; Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Compounding; Drug Delivery Systems; Humans; Isoquinolines; Liposomes; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; N-Acetylneuraminic Acid; Neutrophils; Particle Size; Polymers; Tumor Microenvironment

2018